相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-Resolution Diffusion-Weighted Imaging of C6 Glioma on a 7T BioSpec MRI Scanner: Correlation of Tumor Cellularity and Nuclear-to-Cytoplasmic Ratio with Apparent Diffusion Coefficient
Pang Haopeng et al.
ACADEMIC RADIOLOGY (2022)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Diffusion-weighted magnetic resonance spectroscopy enables cell-specific monitoring of astrocyte reactivity in vivo
Clemence Ligneu et al.
NEUROIMAGE (2019)
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence
Sevin Turcan et al.
NATURE GENETICS (2018)
Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy
Francesca Branzoli et al.
NEURO-ONCOLOGY (2018)
2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data
Chong Hyun Suh et al.
NEURO-ONCOLOGY (2018)
FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas
Alberto Picca et al.
NEUROLOGY (2018)
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate
Ovidiu C. Andronesi et al.
NATURE COMMUNICATIONS (2018)
A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence
Camila Ferreira de Souza et al.
CELL REPORTS (2018)
Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and hydrophobicity at residue 132 on catalytic efficiency
Diego Avellaneda Matteo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
Michael Weller et al.
LANCET ONCOLOGY (2017)
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1
Tali Mazor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations
Uzay E. Emir et al.
CANCER RESEARCH (2016)
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
Ovidiu C. Andronesi et al.
CLINICAL CANCER RESEARCH (2016)
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
Macarena I. de la Fuente et al.
NEURO-ONCOLOGY (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma
Changho Choi et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome
F. Favero et al.
ANNALS OF ONCOLOGY (2015)
MRI Segmentation of the Human Brain: Challenges, Methods, and Applications
Ivana Despotovic et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2015)
The Potential for Isocitrate Dehydrogenase Mutations to Produce 2-Hydroxyglutarate Depends on Allele Specificity and Subcellular Compartmentalization
Patrick S. Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A comparative study of short- and long-TE 1H MRS at 3 T for in vivo detection of 2-hydroxyglutarate in brain tumors
Changho Choi et al.
NMR IN BIOMEDICINE (2013)
Detection of oncometabolite 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma
Juliya Kalinina et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas
Changho Choi et al.
NATURE MEDICINE (2012)
Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy
Ovidiu C. Andronesi et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
M. J. van den Bent et al.
LANCET ONCOLOGY (2011)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
M. Labussiere et al.
NEUROLOGY (2010)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
Paul A. Yushkevich et al.
NEUROIMAGE (2006)
Advances in functional and structural MR image analysis and implementation as FSL
SM Smith et al.
NEUROIMAGE (2004)
Role of proton magnetic resonance spectroscopy in the diagnosis of gliomatosis cerebri - A unique pattern of normal choline but elevated myo-inositol metabolite levels
AVR Mohana-Borges et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2004)
How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging
JLR Andersson et al.
NEUROIMAGE (2003)
分享论文
